Nisa LEUNG
Board Member, HKUST Business School Advisory Council
Managing Partner, Qiming Venture Partners

Nisa is Managing Partner of Qiming Venture Partners, leading its health care investments. Qiming Venture Partners is a leading investment firm in China with over 430 portfolio companies. 

She is currently a Board Member of the HKUST Business School Advisory Council. She also sits on board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics (SSE:688185; HKSE:6185), dMed, Chain Medical Labs, Berry Oncology, Belief BioMed, ZhenGe, Valgen among others. Her other investments include Gan & Lee (SSE:603087), New Horizon Health (HKSE:6606), Venus MedTech (HKSE:2500), Aeonmed Medical, Berry Genomics (SZSE:000710), Broncus (HKSE:2216), CITIC Pharma (acquired by Shanghai Pharmaceutical HKSE: 2607), Crown Bioscience (acquired by JSR Life Sciences), Kira Pharmaceutical, LIH, Novast Pharmaceuticals, Nurotron, Origene Technologies (acquired by VCAN Bio SSE:600645), Richen, Wuxi Leiming, MEDx, Cure Genetics, Goodwill (SSE:688246), SinoCell Tech (SSE:688520), Sino Biological (SZSE:301047), Apollomics, Sino United, Schrödinger (NASDAQ:SDGR), Shouti, Jacobio (HKSE:1167), Hope Medicine, Insilico Medicine, Alamar among others.

Prior to joining Qiming, she was co-founder of Biomedic Holdings with operations and investments in medical devices, pharmaceuticals and health care services in China including Novamed Pharmaceuticals (acquired by SciClone NASDAQ:SCLN) and U-Systems (acquired by GE Healthcare). Nisa was Venture Partner of PacRim Ventures in Menlo Park, and was previously with Softbank/Mobius Venture Capital.

Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019, 2020, 2021 and 2022 and named Best Women VCs List by Forbes China (#1 in 2022, #2 in 2021).

Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as an independent non-executive director of the Hong Kong Exchanges and Clearing Limited (“HKEX”) and Hong Kong Palace Museum

Helen CHEN
Head, External & Alumni Relations
HKUST Business School

Helen is the Head of External and Alumni Relations at HKUST Business School, responsible for building the School’s presence and connectivity with the business community globally. 

Prior to joining the School, Helen was the Head of Strategic Development at Asia Society Hong Kong Center, in charge of external partnerships and fundraising. She has over two decades of experience in the financial industry, spanning Hong Kong and Japan. Helen was also a faculty member of the Hitotsubashi University School of International Corporate Strategy in Japan.  

Actively engaged with the community, she is a Senior Advisor to the Columbia University Alumni Association Hong Kong, the President of Zonta Club of Victoria, and a member of Baixian Asia Institute’s Communications and Development Committee.